3rd Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Labor-Health and Human Services Appropriations and asked for additional Food and Drug Administration (FDA) funding. Letter to NIOSH (CDC) on E-health records.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare program, outpatient hospital payment, Part D, and Conditions of Participation regarding single use vials of drugs and drug shortages.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); SENATE; Food & Drug Administration (FDA)

Pharmacy PHA

S. 3187, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN —
CHRISTOPHER J TOPOLESKI —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 3187 (112th), H.R. 6413 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.